Mike Crews
Analyst · Nomura Instinet. Please go ahead
Well, thank you, Jim, and good morning. I will review the results for the second quarter and our 2018 outlook. Beginning on Slide 4, this quarter marks another period of solid performance for PQ. Sales increased nearly 12% to $435 million and adjusted EBITDA by 5% to $129 million, driven primarily by higher volumes in both Performance Materials and performance chemicals. It was also a very good quarter for hydrocracking catalysts sales within the Zeolyst joint venture. As we discussed last quarter, and similar to the first quarter, adjusted EBITDA margin was approximately 27%, largely impacted by timing of maintenance and turnaround cost, coupled with the pass-through of higher raw material prices in Refining Services. Just to recap, we passed raw material price increases or decreases through to our customers for our contracts. For sulfur specifically, while there's no impact to our adjusted EBITDA or earnings, it does impact our margins. Our cash flow profile continues to improve. First half free cash flow increased $23 million, largely due to lower cash interest. So let's move to a review of the business segment performance, beginning with Environmental Catalyst and Services segment, or EC&S, on Slide 5. Sales increased more than 4% to $129 million and adjusted EBITDA rose to $65 million, largely driven by higher pricing from the pass-through of increased sulfur cost, volume growth in Refining Services and higher Polyolefin Catalysts sales, which was partially offset by lower chemical catalysts or MMA sales, due to the timing of customer orders. Sales in the Zeolyst joint venture grew 61% to nearly $50 million, led by higher hydrocracking catalyst sales from a large number of refinery change outs. Segment adjusted EBITDA margins of approximately 36% declined largely due to the higher maintenance cost and cost pass-through as we previously described. But given lower expected maintenance and turnaround cost in the second half of 2018, we expect full year segment margins to approximate LTM ended June levels or 38%. Turning to the Performance Materials & Chemicals segment, or PM&C, on Slide 6. PM&C sales increased 15% to approximately $306 million. Performance Materials grew by 27% due to contributions from Sovitec combined with demand growth and transportation safety, including ThermoDrop. Performance chemicals rose nearly 9% on higher sodium silicate demand for industrial applications. Adjusted EBITDA grew 11% to nearly $74 million. This was largely a benefit from higher volumes in both product groups, coupled with the absence of start-up costs associated with ThermoDrop in the prior year. Adjusted EBITDA margin was 24%, modestly lower due to sales mix. Moving to Slide 7, I will discuss our full year 2018 outlook. With our solid performance for the first half of 2018 and continued strength in the demand drivers covered by Jim, we are reaffirming our financial guidance with a couple of revisions. We continue to expect top line growth to be in the range of 5% to 7%, excluding the Zeolyst joint venture sales. For the JV, we expect sales growth to be more in the mid-single-digit range, as hydrocracking catalyst sales were concentrated in the first half of the year. Over the year, EC&S is expected to grow in the mid-single-digit range while PM&C is expected to grow in the high single-digit range. Our forecast of 4% to 8% growth in adjusted EBITDA remains unchanged. There are a few items I would like to highlight. So given our contract cost pass-through structures, we believe our portfolio remains well insulated from inflation pressures. While we are closely monitoring the tariff situation, at this time we do not believe we will have any material impact from tariffs. And finally, on D&A, we are now expecting to be in a higher range of $185 million to $190 million due to higher D&A related to the Sovitec acquisition. Please note, we have also provided the Zeolyst joint venture D&A separately as that is also added back to calculate adjusted EBITDA but is excluded from adjusted net income. With higher anticipated margins in the second half, adjusted EBITDA margin is expected to be largely in line with 2017 levels, but we do expect a 70 basis point negative impact from higher cost pass-throughs to be permanent to the year. Our interest expense outlook remains unchanged. As we discussed on our last call, the $1 billion notional amount of interest rate caps that we have in place through mid-2020, significantly limits our exposure in a rising interest rate environment. And based upon our year-to-date results, we are changing our effective tax rate guidance from the mid-30% range to approximately 30%. Capital expenditures are still expected to be in the $150 million to $155 million range and include approximately $40 million for growth capital. And we are still targeting free cash flow in the range of $120 million to $140 million. Due to seasonality, free cash flow was negative in the first two quarters, but that will be more than offset by cash generated in the second half of this year to meet our targets. We will finalize our plans by the end of the third quarter and provide you an update on our next earnings call. We also remain committed to using this free cash flow to lower our leverage ratio by after turn a by year-end. So to summarize, we are pleased with our first half performance, we are on track for our 2018 outlook, given continued underlying demand drivers in our key markets and we operate from a position of financial strength, given our outlook for continued growth and margin sustainability and balance sheet flexibility. So with that, I'll turn the call back to Jim.